Phenobarbital (Page 2 of 2)
Treatment
General management should consist of symptomatic and supportive therapy, including gastric lavage, administration of intravenous fluids, and maintenance of blood pressure, body temperature and adequate respiratory exchange. Dialysis will increase the rate of removal of barbiturates from the body fluids. Antibiotics may be required to control pulmonary complications.
DOSAGE AND ADMINISTRATION
Oral Sedative Dose
Adults: 30 to 120 mg daily in 2 or 3 divided doses.
Children: 6 mg/kg of body weight daily in 3 divided doses.
Oral Hypnotic Dose
Adults: 100 to 320 mg.
Oral Anticonvulsant Dose,
Adults: 50 to 100 mg 2 or 3 times daily.
Children: 15 to 50 mg 2 or 3 times daily.
HOW SUPPLIED
Phenobarbital Tablets USP, 15 mg
White, Round Tablet; Debossed “WW 445” on one side and plain on the other side.
NDC 0143-1495-01: Bottle of 100 tablets
NDC 0143-1495-05: Bottle of 500 tablets
Phenobarbital Tablets USP, 30 mg
White, Round, Scored Tablet; Debossed “WW 450” on one side and Scored on the other side.
NDC 0143-1500-01: Bottle of 100 tablets
NDC 0143-1500-05: Bottle of 500 tablets
Phenobarbital Tablets USP, 60 mg
White, Round Tablet; Debossed “WW 455” on one side and plain on the other side.
NDC 0143-1455-01: Bottle of 100 tablets
NDC 0143-1455-05: Bottle of 500 tablets
Phenobarbital Tablets USP, 100 mg
White, Round, Scored Tablet; Debossed “WW 458” on one side and Scored on the other side.
NDC 0143-1458-01: Bottle of 100 tablets
NDC 0143-1458-05: Bottle of 500 tablets
Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture.
Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
Distributed by:
Hikma Pharmaceuticals USA Inc.
Berkeley Heights, NJ 07922
C50000803/02 Revised August 2022
PRINCIPAL DISPLAY PANEL
NDC 0143-1495-01
Phenobarbital Tablets USP
15 mg
100 Tablets
Rx Only
PRINCIPAL DISPLAY PANEL
NDC 0143-1500-01
Phenobarbital Tablets USP
30 mg
100 Tablets
Rx Only
PRINCIPAL DISPLAY PANEL
NDC 0143-1455-01
Phenobarbital Tablets USP
60 mg
100 Tablets
Rx Only
PRINCIPAL DISPLAY PANEL
NDC 0143-1458-01
Phenobarbital Tablets USP
100 mg
100 Tablets
Rx Only
PRINCIPAL DISPLAY PANEL
blank-image.jpgPRINCIPAL DISPLAY PANEL
pheno-new-image.jpgPHENOBARBITAL phenobarbital tablet | ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
| ||||||||||||||||||
|
PHENOBARBITAL phenobarbital tablet | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
PHENOBARBITAL phenobarbital tablet | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
PHENOBARBITAL phenobarbital tablet | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Labeler — Hikma Pharmaceuticals USA Inc. (001230762) |
Revised: 12/2023 Hikma Pharmaceuticals USA Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.